Report Detail
Global All Vaccine Market Growth 2019-2024
- RnM2872494 |
- 04 February, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).
The average price of China All Vaccine is in the increasing trend, from 2.93 USD/Dose in 2012 to 4.27 USD/Dose in 2016. With the situation of global economy, prices will be in increasing trend in the following five years.
The classification of China All Vaccine includes Polio, Pertussis, Diphtheria, Tetanus, BCG, Rabies, Hepatitis B, Pneumococcal, Hepatitis A, Varicella, Influenza and others and the proportion of Pertussis, Diphtheria and Tetanus in 2016 is about 20.15%, and the proportion is in fluctuation trend from 2012 to 2016.
According to this study, over the next five years the All Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in All Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of All Vaccine market by product type, application, key manufacturers and key regions and countries.
This study considers the All Vaccine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
For Adult
For Child
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
SANOFI PASTEUR
Novartis
GSK
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global All Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of All Vaccine market by identifying its various subsegments.
Focuses on the key global All Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the All Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of All Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global All Vaccine Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global All Vaccine Consumption 2014-2024
- 2.1.2 All Vaccine Consumption CAGR by Region
- 2.2 All Vaccine Segment by Type
- 2.2.1 Varicella
- 2.2.2 Influenza
- 2.2.3 Polio
- 2.2.4 Hepatitis A
- 2.2.5 Rabies
- 2.2.6 BCG
- 2.2.7 Hepatitis B
- 2.2.8 Pertussis, Diphtheria, tetanus
- 2.2.9 Pneumococcal
- 2.2.10 Others
- 2.3 All Vaccine Consumption by Type
- 2.3.1 Global All Vaccine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global All Vaccine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global All Vaccine Sale Price by Type (2014-2019)
- 2.4 All Vaccine Segment by Application
- 2.4.1 For Adult
- 2.4.2 For Child
- 2.5 All Vaccine Consumption by Application
- 2.5.1 Global All Vaccine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global All Vaccine Value and Market Share by Application (2014-2019)
- 2.5.3 Global All Vaccine Sale Price by Application (2014-2019)
3 Global All Vaccine by Players
- 3.1 Global All Vaccine Sales Market Share by Players
- 3.1.1 Global All Vaccine Sales by Players (2017-2019)
- 3.1.2 Global All Vaccine Sales Market Share by Players (2017-2019)
- 3.2 Global All Vaccine Revenue Market Share by Players
- 3.2.1 Global All Vaccine Revenue by Players (2017-2019)
- 3.2.2 Global All Vaccine Revenue Market Share by Players (2017-2019)
- 3.3 Global All Vaccine Sale Price by Players
- 3.4 Global All Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global All Vaccine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players All Vaccine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 All Vaccine by Regions
- 4.1 All Vaccine by Regions
- 4.1.1 Global All Vaccine Consumption by Regions
- 4.1.2 Global All Vaccine Value by Regions
- 4.2 Americas All Vaccine Consumption Growth
- 4.3 APAC All Vaccine Consumption Growth
- 4.4 Europe All Vaccine Consumption Growth
- 4.5 Middle East & Africa All Vaccine Consumption Growth
5 Americas
- 5.1 Americas All Vaccine Consumption by Countries
- 5.1.1 Americas All Vaccine Consumption by Countries (2014-2019)
- 5.1.2 Americas All Vaccine Value by Countries (2014-2019)
- 5.2 Americas All Vaccine Consumption by Type
- 5.3 Americas All Vaccine Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC All Vaccine Consumption by Countries
- 6.1.1 APAC All Vaccine Consumption by Countries (2014-2019)
- 6.1.2 APAC All Vaccine Value by Countries (2014-2019)
- 6.2 APAC All Vaccine Consumption by Type
- 6.3 APAC All Vaccine Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe All Vaccine by Countries
- 7.1.1 Europe All Vaccine Consumption by Countries (2014-2019)
- 7.1.2 Europe All Vaccine Value by Countries (2014-2019)
- 7.2 Europe All Vaccine Consumption by Type
- 7.3 Europe All Vaccine Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa All Vaccine by Countries
- 8.1.1 Middle East & Africa All Vaccine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa All Vaccine Value by Countries (2014-2019)
- 8.2 Middle East & Africa All Vaccine Consumption by Type
- 8.3 Middle East & Africa All Vaccine Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 All Vaccine Distributors
- 10.3 All Vaccine Customer
11 Global All Vaccine Market Forecast
- 11.1 Global All Vaccine Consumption Forecast (2019-2024)
- 11.2 Global All Vaccine Forecast by Regions
- 11.2.1 Global All Vaccine Forecast by Regions (2019-2024)
- 11.2.2 Global All Vaccine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global All Vaccine Forecast by Type
- 11.8 Global All Vaccine Forecast by Application
12 Key Players Analysis
- 12.1 CNBG
- 12.1.1 Company Details
- 12.1.2 All Vaccine Product Offered
- 12.1.3 CNBG All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 CNBG News
- 12.2 ChengDa Bio
- 12.2.1 Company Details
- 12.2.2 All Vaccine Product Offered
- 12.2.3 ChengDa Bio All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 ChengDa Bio News
- 12.3 Changsheng Life
- 12.3.1 Company Details
- 12.3.2 All Vaccine Product Offered
- 12.3.3 Changsheng Life All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Changsheng Life News
- 12.4 Zhifei
- 12.4.1 Company Details
- 12.4.2 All Vaccine Product Offered
- 12.4.3 Zhifei All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Zhifei News
- 12.5 SINOVAC BIOTECH
- 12.5.1 Company Details
- 12.5.2 All Vaccine Product Offered
- 12.5.3 SINOVAC BIOTECH All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 SINOVAC BIOTECH News
- 12.6 NuoCheng Bio
- 12.6.1 Company Details
- 12.6.2 All Vaccine Product Offered
- 12.6.3 NuoCheng Bio All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 NuoCheng Bio News
- 12.7 Hualan Bio
- 12.7.1 Company Details
- 12.7.2 All Vaccine Product Offered
- 12.7.3 Hualan Bio All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Hualan Bio News
- 12.8 Kangtai
- 12.8.1 Company Details
- 12.8.2 All Vaccine Product Offered
- 12.8.3 Kangtai All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Kangtai News
- 12.9 SANOFI PASTEUR
- 12.9.1 Company Details
- 12.9.2 All Vaccine Product Offered
- 12.9.3 SANOFI PASTEUR All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 SANOFI PASTEUR News
- 12.10 Novartis
- 12.10.1 Company Details
- 12.10.2 All Vaccine Product Offered
- 12.10.3 Novartis All Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Novartis News
- 12.11 GSK
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on All Vaccine . Industry analysis & Market Report on All Vaccine is a syndicated market report, published as Global All Vaccine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of All Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
